{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:52:00Z","timestamp":1785163920548,"version":"3.55.0"},"reference-count":46,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.5551\/jat.rv22045","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T22:07:24Z","timestamp":1761343644000},"page":"13-19","source":"Crossref","is-referenced-by-count":5,"title":["Critical Role of microRNA-33a\/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives"],"prefix":"10.5551","volume":"33","author":[{"given":"Takahiro","family":"Horie","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Tsujisaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Vaduganathan M, Mensah GA, Turco JV, Fuster V, and Roth GA. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. J Am Coll Cardiol, 2022; 80: 2361-2371","DOI":"10.1016\/j.jacc.2022.11.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, Lim WH, Huang DQ, Quek J, Fu CE, Xiao J, Syn N, Foo R, Khoo CM, Wang JW, Dimitriadis GK, Young DY, Siddiqui MS, Lam CSP, Wang Y, Figtree GA, Chan MY, Cummings DE, Noureddin M, Wong VW, Ma RCW, Mantzoros CS, Sanyal A, and Muthiah MD. The global burden of metabolic disease: Data from 2000 to 2019. Cell Metab, 2023; 35: 414-428. e413","DOI":"10.1016\/j.cmet.2023.02.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lee RC, Feinbaum RL, and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993; 75: 843-854","DOI":"10.1016\/0092-8674(93)90529-Y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wightman B, Ha I, and Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 1993; 75: 855-862","DOI":"10.1016\/0092-8674(93)90530-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fern\u00e1ndez-Hernando C, and Moore KJ. MicroRNA modulation of cholesterol homeostasis. Arterioscler Thromb Vasc Biol, 2011; 31: 2378-2382","DOI":"10.1161\/ATVBAHA.111.226688"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rottiers V, and N\u00e4\u00e4r AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol, 2012; 13: 239-250","DOI":"10.1038\/nrm3313"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Horie T, Baba O, Kuwabara Y, Yokode M, Kita T, Kimura T, and Ono K. MicroRNAs and Lipoprotein Metabolism. J Atheroscler Thromb, 2014; 21: 17-22","DOI":"10.5551\/jat.20859"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Price NL, Goedeke L, Su\u00e1rez Y, and Fern\u00e1ndez-Hernando C. miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches. EMBO Mol Med, 2021; 13: e12606","DOI":"10.15252\/emmm.202012606"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shimano H, and Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol, 2017; 13: 710-730","DOI":"10.1038\/nrendo.2017.91"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Koyama S, Horie T, Nishino T, Baba O, Sowa N, Miyasaka Y, Kuwabara Y, Nakao T, Nishiga M, Nishi H, Nakashima Y, Nakazeki F, Ide Y, Kimura M, Tsuji S, Ruiz Rodriguez R, Xu S, Yamasaki T, Otani C, Watanabe T, Nakamura T, Hasegawa K, Kimura T, and Ono K. Identification of Differential Roles of MicroRNA-33a and -33b During Atherosclerosis Progression With Genetically Modified Mice. J Am Heart Assoc, 2019; 8: e012609","DOI":"10.1161\/JAHA.119.012609"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, and N\u00e4\u00e4r AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science, 2010; 328: 1566-1569","DOI":"10.1126\/science.1189123"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rayner KJ, Su\u00e1rez Y, D\u00e1valos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, and Fern\u00e1ndez-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science, 2010; 328: 1570-1573","DOI":"10.1126\/science.1189862"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Marquart TJ, Allen RM, Ory DS, and Bald\u00e1n A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A, 2010; 107: 12228-12232","DOI":"10.1073\/pnas.1005191107"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y, Hasegawa K, Yokode M, Kimura T, and Kita T. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci U S A, 2010; 107: 17321-17326","DOI":"10.1073\/pnas.1008499107"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, Leclercq IA, MacDougald OA, and Bommer GT. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem, 2010; 285: 33652-33661","DOI":"10.1074\/jbc.M110.152090"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Nakazeki F, Ide Y, Koyama S, Sowa N, Yahagi N, Shimano H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, and Ono K. MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo. Sci Rep, 2014; 4: 5312","DOI":"10.1038\/srep05312"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, Khatsenko OG, Kaimal V, Lees CJ, Fernandez-Hernando C, Fisher EA, Temel RE, and Moore KJ. Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature, 2011; 478: 404-407","DOI":"10.1038\/nature10486"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Rottiers V, Obad S, Petri A, McGarrah R, Lindholm MW, Black JC, Sinha S, Goody RJ, Lawrence MS, deLemos AS, Hansen HF, Whittaker S, Henry S, Brookes R, Najafi-Shoushtari SH, Chung RT, Whetstine JR, Gerszten RE, Kauppinen S, and N\u00e4\u00e4r AM. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci Transl Med, 2013; 5: 212ra162","DOI":"10.1126\/scitranslmed.3006840"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ouimet M, Hennessy EJ, van Solingen C, Koelwyn GJ, Hussein MA, Ramkhelawon B, Rayner KJ, Temel RE, Perisic L, Hedin U, Maegdefessel L, Garabedian MJ, Holdt LM, Teupser D, and Moore KJ. miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux. Arterioscler Thromb Vasc Biol, 2016, 36: 942-951","DOI":"10.1161\/ATVBAHA.116.307282"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Endo Y, Sasaki K, and Ikewaki K. Bridging the Gap Between the Bench and Bedside: Clinical Applications of High-density Lipoprotein Function. J Atheroscler Thromb, 2024; 31: 1239-1248","DOI":"10.5551\/jat.RV22020"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, and Moore KJ. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest, 2011; 121: 2921-2931","DOI":"10.1172\/JCI57275"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Horie T, Baba O, Kuwabara Y, Chujo Y, Watanabe S, Kinoshita M, Horiguchi M, Nakamura T, Chonabayashi K, Hishizawa M, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, and Ono K. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-\/- mice. J Am Heart Assoc, 2012; 1: e003376","DOI":"10.1161\/JAHA.112.003376"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Rotllan N, Ram\u00edrez CM, Aryal B, Esau CC, and Fern\u00e1ndez-Hernando C. Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-\/- mice--brief report. Arterioscler Thromb Vasc Biol, 2013; 33: 1973-1977","DOI":"10.1161\/ATVBAHA.113.301732"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Nakao T, Horie T, Baba O, Nishiga M, Nishino T, Izuhara M, Kuwabara Y, Nishi H, Usami S, Nakazeki F, Ide Y, Koyama S, Kimura M, Sowa N, Ohno S, Aoki H, Hasegawa K, Sakamoto K, Minatoya K, Kimura T, and Ono K. Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways. Arterioscler Thromb Vasc Biol, 2017; 37: 2161-2170","DOI":"10.1161\/ATVBAHA.117.309768"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Baba O, Horie T, Nakao T, Hakuno D, Nakashima Y, Nishi H, Kuwabara Y, Nishiga M, Nishino T, Ide Y, Nakazeki F, Koyama S, Kimura M, Hanada R, Kawahara M, Kimura T, and Ono K. MicroRNA 33 Regulates the Population of Peripheral Inflammatory Ly6C. Mol Cell Biol, 2018; 38: e00604-17","DOI":"10.1128\/MCB.00604-17"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ouimet M, Ediriweera HN, Gundra UM, Sheedy FJ, Ramkhelawon B, Hutchison SB, Rinehold K, van Solingen C, Fullerton MD, Cecchini K, Rayner KJ, Steinberg GR, Zamore PD, Fisher EA, Loke P, and Moore KJ. MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest, 2015; 125: 4334-4348","DOI":"10.1172\/JCI81676"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Karunakaran D, Thrush AB, Nguyen MA, Richards L, Geoffrion M, Singaravelu R, Ramphos E, Shangari P, Ouimet M, Pezacki JP, Moore KJ, Perisic L, Maegdefessel L, Hedin U, Harper ME, and Rayner KJ. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis. Circ Res, 2015; 117: 266-278","DOI":"10.1161\/CIRCRESAHA.117.305624"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ouimet M, Ediriweera H, Afonso MS, Ramkhelawon B, Singaravelu R, Liao X, Bandler RC, Rahman K, Fisher EA, Rayner KJ, Pezacki JP, Tabas I, and Moore KJ. microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis. Arterioscler Thromb Vasc Biol, 2017; 37: 1058-1067","DOI":"10.1161\/ATVBAHA.116.308916"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ahangari F, Price NL, Malik S, Chioccioli M, B\u00e4rnthaler T, Adams TS, Kim J, Pradeep SP, Ding S, Cosmos C, Rose KS, McDonough JE, Aurelien NR, Ibarra G, Omote N, Schupp JC, DeIuliis G, Villalba Nunez JA, Sharma L, Ryu C, Dela Cruz CS, Liu X, Prasse A, Rosas I, Bahal R, Fern\u00e1ndez-Hernando C, and Kaminski N. microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis. JCI Insight, 2023; 8: e158100","DOI":"10.1172\/jci.insight.158100"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Afonso MS, Sharma M, Schlegel M, van Solingen C, Koelwyn GJ, Shanley LC, Beckett L, Peled D, Rahman K, Giannarelli C, Li H, Brown EJ, Khodadadi-Jamayran A, Fisher EA, and Moore KJ. miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques. Circ Res, 2021; 128: 1122-1138","DOI":"10.1161\/CIRCRESAHA.120.317914"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Zhang X, Rotllan N, Canfr\u00e1n-Duque A, Sun J, Toczek J, Moshnikova A, Malik S, Price NL, Araldi E, Zhong W, Sadeghi MM, Andreev OA, Bahal R, Reshetnyak YK, Su\u00e1rez Y, and Fern\u00e1ndez-Hernando C. Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression. Circ Res, 2022; 131: 77-90","DOI":"10.1161\/CIRCRESAHA.121.320296"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Nishino T, Horie T, Baba O, Sowa N, Hanada R, Kuwabara Y, Nakao T, Nishiga M, Nishi H, Nakashima Y, Nakazeki F, Ide Y, Koyama S, Kimura M, Nagata M, Yoshida K, Takagi Y, Nakamura T, Hasegawa K, Miyamoto S, Kimura T, and Ono K. SREBF1\/MicroRNA-33b Axis Exhibits Potent Effect on Unstable Atherosclerotic Plaque Formation In Vivo. Arterioscler Thromb Vasc Biol, 2018; 38: 2460-2473","DOI":"10.1161\/ATVBAHA.118.311409"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Yamasaki T, Horie T, Koyama S, Nakao T, Baba O, Kimura M, Sowa N, Sakamoto K, Yamazaki K, Obika S, Kasahara Y, Kotera J, Oka K, Fujita R, Sasaki T, Takemiya A, Hasegawa K, Minatoya K, Kimura T, and Ono K. Inhibition of microRNA-33b specifically ameliorates abdominal aortic aneurysm formation via suppression of inflammatory pathways. Sci Rep, 2022; 12: 11984","DOI":"10.1038\/s41598-022-16017-5"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) D\u00e1valos A, Goedeke L, Smibert P, Ram\u00edrez CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U, Pastor-Pareja JC, Esplugues E, Fisher EA, Penalva LO, Moore KJ, Su\u00e1rez Y, Lai EC, and Fern\u00e1ndez-Hernando C. miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A, 2011; 108: 9232-9237","DOI":"10.1073\/pnas.1102281108"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Goedeke L, Vales-Lara FM, Fenstermaker M, Cirera-Salinas D, Chamorro-Jorganes A, Ram\u00edrez CM, Mattison JA, de Cabo R, Su\u00e1rez Y, and Fern\u00e1ndez-Hernando C. A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol Cell Biol, 2013; 33: 2339-2352","DOI":"10.1128\/MCB.01714-12"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Price NL, Zhang X, Fern\u00e1ndez-Tussy P, Singh AK, Burnap SA, Rotllan N, Goedeke L, Sun J, Canfr\u00e1n-Duque A, Aryal B, Mayr M, Su\u00e1rez Y, and Fern\u00e1ndez-Hernando C. Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis. Proc Natl Acad Sci U S A, 2021; 118: e2006478118","DOI":"10.1073\/pnas.2006478118"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Fern\u00e1ndez-Tussy P, Cardelo MP, Zhang H, Sun J, Price NL, Boutagy NE, Goedeke L, Cadena-Sandoval M, Xirouchaki CE, Brown W, Yang X, Pastor-Rojo O, Haeusler RA, Bennett AM, Tiganis T, Su\u00e1rez Y, and Fern\u00e1ndez-Hernando C. miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression. JCI Insight, 2024; 9: e168476","DOI":"10.1172\/jci.insight.168476"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Miyagawa S, Horie T, Nishino T, Koyama S, Watanabe T, Baba O, Yamasaki T, Sowa N, Otani C, Matsushita K, Kojima H, Kimura M, Nakashima Y, Obika S, Kasahara Y, Kotera J, Oka K, Fujita R, Sasaki T, Takemiya A, Hasegawa K, Kimura T, and Ono K. Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis. Life Sci Alliance, 2023; 6: e202301902","DOI":"10.26508\/lsa.202301902"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa N, Yahagi N, Shimano H, Matsumura S, Inoue K, Marusawa H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, and Ono K. MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun, 2013; 4: 2883","DOI":"10.1038\/ncomms3883"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Price NL, Singh AK, Rotllan N, Goedeke L, Wing A, Canfr\u00e1n-Duque A, Diaz-Ruiz A, Araldi E, Bald\u00e1n \u00c1, Camporez JP, Su\u00e1rez Y, Rodeheffer MS, Shulman GI, de Cabo R, and Fern\u00e1ndez-Hernando C. Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance. Cell Rep, 2018; 22: 2133-2145","DOI":"10.1016\/j.celrep.2018.01.074"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Price NL, Fern\u00e1ndez-Tussy P, Varela L, Cardelo MP, Shanabrough M, Aryal B, de Cabo R, Su\u00e1rez Y, Horvath TL, and Fern\u00e1ndez-Hernando C. microRNA-33 controls hunger signaling in hypothalamic AgRP neurons. Nat Commun, 2024; 15: 2131","DOI":"10.1038\/s41467-024-46427-0"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Jovasevic V, Corcoran KA, Leaderbrand K, Yamawaki N, Guedea AL, Chen HJ, Shepherd GM, and Radulovic J. GABAergic mechanisms regulated by miR-33 encode state-dependent fear. Nat Neurosci, 2015; 18: 1265-1271","DOI":"10.1038\/nn.4084"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Horie T, Nakao T, Miyasaka Y, Nishino T, Matsumura S, Nakazeki F, Ide Y, Kimura M, Tsuji S, Rodriguez RR, Watanabe T, Yamasaki T, Xu S, Otani C, Miyagawa S, Matsushita K, Sowa N, Omori A, Tanaka J, Nishimura C, Nishiga M, Kuwabara Y, Baba O, Watanabe S, Nishi H, Nakashima Y, Picciotto MR, Inoue H, Watanabe D, Nakamura K, Sasaki T, Kimura T, and Ono K. microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity. Nat Commun, 2012; 12: 843","DOI":"10.1038\/s41467-021-21107-5"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Afonso MS, Verma N, van Solingen C, Cyr Y, Sharma M, Perie L, Corr EM, Schlegel M, Shanley LC, Peled D, Yoo JY, Schmidt AM, Mueller E, and Moore KJ. MicroRNA-33 Inhibits Adaptive Thermogenesis and Adipose Tissue Beiging. Arterioscler Thromb Vasc Biol, 2021; 41: 1360-1373","DOI":"10.1161\/ATVBAHA.120.315798"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Sowa N, Horie T, Ide Y, Baba O, Kora K, Yoshida T, Nakamura Y, Matsumura S, Matsushita K, Imanaka M, Zou F, Kume E, Kojima H, Qian Q, Kimura K, Otsuka R, Hara N, Yamasaki T, Otani C, Tsujisaka Y, Takaya T, Nishimura C, Watanabe D, Hasegawa K, Kotera J, Oka K, Fujita R, Takemiya A, Sasaki T, Kasahara Y, Obika S, Kimura T, and Ono K. MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration. EMBO Mol Med, 2025; 17: 1902-1925","DOI":"10.1038\/s44321-025-00273-9"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Lopez MA, and Alexander MS. miR-33 inhibition as a novel therapeutic approach for treating muscular dystrophy. EMBO Mol Med, 2025; 17: 1893-1895","DOI":"10.1038\/s44321-025-00271-x"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/1\/33_RV22045\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:18:15Z","timestamp":1767413895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/1\/33_RV22045\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22045","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"RV22045"}}